Azithromcyin

DRUG4 trials

Sponsors

University of California, San Francisco, University of Santiago de Compostela, Bin Cao, The University of Queensland

Conditions

Chlamydia TrachomatisMycobacterium Abscessus InfectionMycobacterium Abscessus Pulmonary DiseaseMycobacterium Avium Complex Pulmonary DiseaseNon-Tuberculous Mycobacteria Pulmonary DiseaseNon-Tuberculous Mycobacterial (NTM) InfectionsPeri-implantitisTrachoma

Phase 2

Testing a Novel Combination Treatment (Arm D) Versus Standard of Care for Intensive Phase Treatment for Mycobacterium Abscessus Pulmonary Disease in People With or Without Cystic Fibrosis in the Finding the Optimal Regimen for Mycobacterium Abscessus Treatment (FORMaT) Adaptive Platform Trial

Not yet recruitingNCT07485010

The University of QueenslandMycobacterium Abscessus Infection, Mycobacterium Abscessus Pulmonary Disease, Non-Tuberculous Mycobacterial (NTM) Infections +1

Start: 2027-04-01End: 2031-07-01Target: 300Updated: 2026-03-20

Phase 4

Impact of Two Alternative Dosing Strategies for Trachoma Control in Niger

CompletedNCT00618449

University of California, San FranciscoChlamydia Trachomatis, Trachoma

Start: 2008-01-31End: 2009-08-31Updated: 2012-05-08

Non-Surgical Treatment of Peri-implantitis with Systemic Azithromycin or Placebo

Not yet recruitingNCT06715150

University of Santiago de CompostelaPeri-implantitis

Start: 2025-01-10End: 2027-01-10Target: 52Updated: 2024-12-10

Short-term Bactericidal Effect of Contezolid in MAC-PD

RecruitingNCT07084402

Bin CaoMycobacterium Avium Complex Pulmonary Disease

Start: 2025-07-24End: 2027-12-31Target: 188Updated: 2025-09-18